Development and validation of a reversed‐phase high‐performance liquid chromatography–ultraviolet method for abemaciclib‐related substance detection in bulk drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and validation of a reversed‐phase high‐performance liquid chromatography–ultraviolet method for abemaciclib‐related substance detection in bulk drugs

Published:2022-09-20 Issue:22 Volume:45 Page:4070-4078
ISSN:1615-9306
Container-title:Journal of Separation Science
language:en
Short-container-title:J of Separation Science

Author:

Ni Ronghua¹,Du Xiao²,Huang Rongrong¹,Wu Wenyi³,Xu Jingqiu¹,Ma Xiaofei¹,Cai Liangliang¹^ORCID

Affiliation:

1. Department of Pharmacy Affiliated Hospital of Nantong University Nantong P. R. China

2. Department of Pharmacy Nanjing Medical Center for Clinical Pharmacy Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing P. R. China

3. Department of quality inspection Sinopharm Holding Nantong Ltd Nantong P. R. China

Funder

National Natural Science Foundation of China

Postdoctoral Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Filtration and Separation,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jssc.202200551

Reference17 articles.

1. Breast cancer

2. Cyclin D-CDK4/6 functions in cancer

3. Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

4. https://www.fda.gov/drugs/resources‐information‐approved‐drugs/fda‐approves‐abemaciclib‐hr‐positive‐her2‐negative‐breast‐cancerAccessed September 28 2019

5. Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP